Paul Bisaro - Oct 31, 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Justin Hunter For: Paul Bisaro
Stock symbol
MYGN
Transactions as of
Oct 31, 2022
Transactions value $
$0
Form type
4
Date filed
11/1/2022, 04:31 PM
Previous filing
Oct 3, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +16.9K $0.00 16.9K Oct 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.